Your browser doesn't support javascript.
loading
Mesenchymal stem/stromal cell-based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19.
Kirkham, Aidan M; Monaghan, Madeline; Bailey, Adrian J M; Shorr, Risa; Lalu, Manoj M; Fergusson, Dean A; Allan, David S.
Afiliación
  • Kirkham AM; Departments of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, ON, Canada; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Monaghan M; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Bailey AJM; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Shorr R; Medical Information and Learning Services, The Ottawa Hospital, Ottawa, ON, Canada.
  • Lalu MM; Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada; Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, ON,
  • Fergusson DA; Medicine, University of Ottawa, Ottawa, ON, Canada; Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Medicine, The Ottawa Hospital, Ottawa, ON, Canada.
  • Allan DS; Departments of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, ON, Canada; Medicine, University of Ottawa, Ottawa, ON, Canada; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa,
Cytotherapy ; 24(6): 639-649, 2022 06.
Article en En | MEDLINE | ID: mdl-35219584

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas / COVID-19 Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas / COVID-19 Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido